CompletedPhase 3NCT00072384
Systemic Chemotherapy and Subtenon Carboplatin, and Local Ophthalmic Therapy in Children With Intraocular Retinoblastoma
Studying Retinoblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Rima Jubran, MDChildren's Oncology Group
- Intervention
- liposomal vincristine sulfate(drug)
- Enrollment
- 30 target
- Eligibility
- 17 years · All sexes
- Timeline
- 2007 – 2021
Study locations (11)
- Children's Oncology Group, Arcadia, California, United States
- Southern California Permanente Medical Group, Downey, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Yale University, New Haven, Connecticut, United States
- Lombardi Comprehensive Cancer Center at Georgetown University, Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States
- University of Illinois, Chicago, Illinois, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Baylor College of Medicine, Houston, Texas, United States
- M D Anderson Cancer Center, Houston, Texas, United States
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00072384 on ClinicalTrials.govOther trials for Retinoblastoma
Additional recruiting or active studies for the same condition.